Covered recipient · General Payments record
MICHAEL DELANEY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2025
$1,650.30
- Reported across 84 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $377.84 | 23 |
| Education | $13.76 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $151.46 | 12 |
| PFIZER INC. | $48.89 | 3 |
| Otsuka America Pharmaceutical, Inc. | $29.05 | 1 |
| Gilead Sciences, Inc. | $27.95 | 1 |
| ITI, Inc. | $26.72 | 1 |
| VERTEX PHARMACEUTICALS INCORPORATED | $23.42 | 1 |
| Novo Nordisk AS | $18.49 | 1 |
| Abbott Laboratories | $17.57 | 1 |
| Lilly USA, LLC | $17.55 | 1 |
| Acerta Pharma LLC | $16.74 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.76 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2025 20202021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $17.57 | 04/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241037401 | CMS |
| ABBVIE INC. | $1.52 | 01/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201746332 | CMS |
| ABBVIE INC. | $23.99 | 01/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201746334 | CMS |
| ABBVIE INC. | $10.75 | 01/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201746336 | CMS |
| ABBVIE INC. | $15.05 | 02/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201746338 | CMS |
| ABBVIE INC. | $1.43 | 03/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201746340 | CMS |
| ABBVIE INC. | $15.27 | 04/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201746342 | CMS |
| ABBVIE INC. | $14.21 | 06/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201746344 | CMS |
| ABBVIE INC. | $8.88 | 11/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201746346 | CMS |
| ABBVIE INC. | $11.06 | 11/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201746348 | CMS |
| ABBVIE INC. | $19.60 | 11/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201746350 | CMS |
| ABBVIE INC. | $18.64 | 11/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201746352 | CMS |
| ABBVIE INC. | $11.06 | 11/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201746354 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.74 | 03/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206744054 | CMS |
| Gilead Sciences, Inc. | $27.95 | 09/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234451824 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $26.72 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241291190 | CMS |
| Lilly USA, LLC | $17.55 | 12/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186808139 | CMS |
| Novo Nordisk Inc | $18.49 | 04/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188207129 | CMS |
| Otsuka America Pharmaceutical, Inc. | $29.05 | 06/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227317432 | CMS |
| PFIZER INC. | $17.84 | 07/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229302436 | CMS |
| PFIZER INC. | $15.18 | 08/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229415089 | CMS |
| PFIZER INC. | $15.87 | 10/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1230684751 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.76 | 08/19/2025 | Education | Undisputed | 06/30/2026 | 1224101926 | CMS |
| VERTEX PHARMACEUTICALS INCORPORATED | $23.42 | 12/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1213890393 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2020, 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.